deuterium-enriched oxybutynin derivatives (Deuteria Pharmaceuticals)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namedeuterium-enriched oxybutynin derivatives (Deuteria Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDeuteria Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDeuteria Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A